Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC 632 Measure Title Measure Source Coronary Artery Bypass Graft (CABG): Anti-platelet Medications at Discharge + STS Coronary Artery Bypass Graft (CABG): Beta Blockade at Discharge + STS Coronary Artery Bypass Graft (CABG): Lipid Management and Counseling + STS Hemodialysis Vascular Access Decision-making by Surgeons to Maximize Placement of Society for Vascular Autogenous Arterial Venous Fistula Surgeons (SVS) + This measure is reportable only via registry-based reporting and is not reportable via claims-based reporting. As previously mentioned in this final rule, we are not finalizing the proposed measure, Use of Imaging Studies in Low Back Pain, in the final 2009 PQRI quality measures set listed in Table 16 based on comments received. In addition, we are not finalizing the following proposed NQF-endorsed measure in the final 2009 PQRI measures because its adaptation to the PQRI format was subsequently found to be not feasible: Selection of Antibiotic Administration for Cardiac Surgery Patients. Substantive components of this measure are duplicative of Measure # 21 Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation Cephalosporin, which is listed in Table 15. As stated above, there are 8 measures listed in Table 16 that can be reported only via a registry for the 2009 PQRI and, therefore, are not reportable via claims- based reporting. As described in the CY 2009 PFS proposed rule (73 FR 38570), measures designated as T### in the proposed

CMS-1403-FC rule indicated that the measure was included in the 2008 Measure Testing Process. The T#### identifier was removed from Table 16 in this final rule with comment because each measure in the final 2009 PQRI quality measures set will be assigned a unique number which may be obtained from the detailed specifications which will be made available on the PQRI section of the CMS Web site no later than December 31, 2008. iii. Additional AQA Adopted Measures As discussed in the CY 2009 PFS proposed rule (73 FR 38565 through 38566), in circumstances where no NQF-endorsed measure is available, a quality measure that has been adopted by the AQA would also meet the requirements of section 1848(k)(2)(B)(i) of the Act. As such, we proposed 21 new measures adopted by the AQA that had not yet been reviewed or endorsed by the NQF at the time the CY 2009 PFS proposed rule was published and that were not included in the final set of 2008 PQRI quality measures (73 FR 38571). We received numerous comments on the 21 proposed additional AQA-adopted measures, which are summarized and addressed below. 633

<strong>CMS</strong>-1403-FC<br />

632<br />

Measure Title Measure Source<br />

Coronary Artery Bypass Graft (CABG): Anti-platelet Medications at Discharge + STS<br />

Coronary Artery Bypass Graft (CABG): Beta Blockade at Discharge + STS<br />

Coronary Artery Bypass Graft (CABG): Lipid Management and Counseling + STS<br />

Hemodialysis Vascular Access Decision-making by Surgeons to Maximize Placement of Society for Vascular<br />

Autogenous Arterial Venous Fistula<br />

Surgeons (SVS)<br />

+<br />

<strong>This</strong> measure is reportable only via registry-based reporting and is not reportable via claims-based<br />

reporting.<br />

As previously mentioned in this final rule, we are not<br />

finalizing the proposed measure, Use of Imaging Studies in<br />

Low Back Pain, in the final 2009 PQRI quality measures set<br />

listed in Table 16 based on comments received.<br />

In addition, we are not finalizing the following<br />

proposed NQF-endorsed measure in the final 2009 PQRI<br />

measures because its adaptation to the PQRI format was<br />

subsequently found to be not feasible: Selection of<br />

Antibiotic Administration for Cardiac Surgery Patients.<br />

Substantive components of this measure are duplicative of<br />

Measure # 21 Perioperative Care: Selection of Prophylactic<br />

Antibiotic - First OR Second Generation Cephalosporin,<br />

which is listed in Table 15.<br />

As stated above, there are 8 measures listed in<br />

Table 16 that can be reported only via a registry for the<br />

2009 PQRI and, therefore, are not reportable via claims-<br />

based reporting.<br />

As described in the CY 2009 PFS proposed rule<br />

(73 FR 38570), measures designated as T### in the proposed

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!